about
Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra LeoneComplexities in Ferret Influenza Virus Pathogenesis and Transmission ModelsHuman antibodies that neutralize respiratory droplet transmissible H5N1 influenza virusesPrognostic Indicators for Ebola Patient SurvivalMammalian Pathogenesis and Transmission of H7N9 Influenza Viruses from Three Waves, 2013-2015Environmental Conditions Affect Exhalation of H3N2 Seasonal and Variant Influenza Viruses and Respiratory Droplet Transmission in FerretsEbola Virus Disease Diagnostics, Sierra Leone: Analysis of Real-time Reverse Transcription-Polymerase Chain Reaction Values for Clinical Blood and Oral Swab Specimens.Influenza virus aerosol exposure and analytical system for ferrets.Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza.Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice.Needle-free skin patch delivery of a vaccine for a potentially pandemic influenza virus provides protection against lethal challenge in mice.H7N9 and other pathogenic avian influenza viruses elicit a three-pronged transcriptomic signature that is reminiscent of 1918 influenza virus and is associated with lethal outcome in miceMammalian models for the study of H7 virus pathogenesis and transmission.DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response.Comparison of traditional intranasal and aerosol inhalation inoculation of mice with influenza A viruses.Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets.Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus sheddingHuman HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air.Resurrected pandemic influenza viruses.Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses.Pathogenesis and Transmission of Novel Highly Pathogenic Avian Influenza H5N2 and H5N8 Viruses in Ferrets and MiceMapping influenza transmission in the ferret model to transmission in humans.Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses.Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal modelsPathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.Constitutively Expressed IFITM3 Protein in Human Endothelial Cells Poses an Early Infection Block to Human Influenza Viruses.NS-based live attenuated H1N1 pandemic vaccines protect mice and ferretsPathogenesis and transmission of triple-reassortant swine H1N1 influenza viruses isolated before the 2009 H1N1 pandemic.Influenza A virus transmission: contributing factors and clinical implications.The development of vaccine viruses against pandemic A(H1N1) influenza.Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets.Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 virusesA single base-pair change in 2009 H1N1 hemagglutinin increases human receptor affinity and leads to efficient airborne viral transmission in ferrets.Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.A novel A(H7N2) influenza virus isolated from a veterinarian caring for cats in a New York City animal shelter causes mild disease and transmits poorly in the ferret model.Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.
P50
Q24696014-C9AEDC26-07CF-4BF4-8DEE-00352608400EQ26740459-4A54D57C-D7E9-4C54-98AB-BDE99292217CQ27679859-6ADE2883-CDBC-45B7-AF7C-1B3EF179A5FBQ28385515-EDFD6351-5DCF-4983-9211-70DC90FA1B37Q28392524-8D190F42-AAA3-401E-A858-477BA4B48682Q28393999-756C5EC9-1961-4FD6-9FF5-CFDA9C6CBD9BQ30151809-14A9AB68-6A43-4F51-AE4D-C4E7DD4C15AFQ30226595-D8032BFA-FEB2-47B0-8FDD-995513A886E3Q30230004-68CB3323-791A-4FAA-8165-1E8AB5278D4BQ30352927-3E1FA910-3FB0-49F4-B8E7-0B942C5EE293Q30361581-08624D0E-A78A-45B3-B472-1C8F1EBAA7D7Q30364306-E3B2D6BA-BF1D-45E0-83A3-531562E915FCQ30364385-C803B00C-3BA8-4C8D-BA96-73F7981F1C16Q30365874-52FA3852-054B-4AD4-9D24-F28DE1179AEAQ30372472-39AE2200-3AB3-4EBC-8988-7F5CABA5A6B2Q30372690-480992B8-3CAA-433F-B5B1-48E70CDC771DQ30372696-9AB8D190-98F1-426C-9F80-C754F60831E2Q30374356-50F8D846-E7F3-4943-9AE6-EBD481794A18Q30374897-4B9101E6-FFB3-4B99-A105-A34078FE823FQ30376358-4D8935A4-63F2-4B8B-8663-CD596446F5E5Q30376814-45C91A40-FC14-4168-8C06-5E5CD20C4797Q30377312-B4A05866-72BD-4731-AB85-1438B6F871A9Q30378661-CA3E23C1-5F88-473C-8981-582E1A7E37CAQ30379985-C444BB1A-61A0-4C8C-B3F5-C50511E46806Q30382312-CCE234B8-1587-49F6-8B90-03B8B26FD330Q30382467-6757CB66-A664-4174-ACF1-E90D384272B8Q30385984-4CAD0026-B7BC-4671-9463-EABB443F6CEDQ30385991-018F960F-9003-4545-9B05-A668D6F865A2Q30393767-16B4CB87-80DE-4D61-9EF7-93DF050F8240Q30394706-8F77D6B2-71AA-4A2A-B608-068E58FD86F1Q30396905-E87D8CC1-5351-490D-BBB8-984FE6A9AB4EQ30397203-004A73A0-87B7-458A-B8C1-E3FB0450A084Q30398053-6E1455F8-96CC-43B6-A0E1-4A4D6B260DC5Q30399923-6405644C-118F-4610-9CFF-8F68D89575B0Q30400680-2559F443-F7DB-4806-B4CC-5469D71B2524Q30400777-77F94268-C4EE-4B51-8F4A-BF2BDC736278Q30401917-75CDF96A-9F64-43A1-8991-9B3D103C52D3Q30402085-EA27AC57-6E62-4F49-96E7-41111A1716B4Q30402500-2B7C2259-118C-42D4-B848-19022B6659CDQ30404415-CCCB0D85-6CCB-4E93-B630-1D55BDE7C80C
P50
name
Jessica A Belser
@en
type
label
Jessica A Belser
@en
prefLabel
Jessica A Belser
@en